Skip to main content

Advertisement

Table 1 Clinicopathological characteristics of patients with esophageal squamous cell carcinoma

From: Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma

Variable The GEO datasetsa The experimental set
Number of patients 5-year OS rate (%) P valueb Number of patients 5-year OS rate (%) P valueb
Total 119    105   
Age (years)
 ≤ 59 89 48.31 0.03 63 58.73 0.69
 > 59 90 33.33 42 54.76
Sex
 Female 33 33.33 0.30 25 48.00 0.16
 Male 146 42.47 80 60.00
Tumor location
 Upper thorax 20 25.00 0.10 7 71.4 0.15
 Middle thorax 97 40.21 54 61.11
 Lower thorax 62 46.78 44 50.00
Histological grade
 G1 49 28.57 0.02 15 60.00 0.16
 G2 98 44.90 73 64.29
 G3 32 46.88 17 47.06
Primary tumor
 T1 12 41.67 0.04 21 71.42 0.03
 T2 27 40.74 63 63.49
 T3 110 44.55 21 31.58
 T4 30 26.67    
Regional lymph nodes
 N0 83 56.62 < 0.01 50 68.00 < 0.01
 N1 62 27.41 32 56.25
 N2 22 27.27 16 37.50
 N3 12 25.00 7 28.50
pTNM stage
 I 10 70.00 0.00 6 33.30 0.00
 II 77 53.25 48 70.80
 III 92 27.17 51 47.05
Adjuvant therapy
 Unknown 45 64.44   0   
 No 30 30.00 0.50 43 58.14 0.70
 Yes 104 33.65 62 56.45
 Radiotherapy Unknown    18 48.83 0.11
 Chemotherapy Unknown    19 59.09
 Radiotherapy + chemotherapy Unknown    25 48.00
  1. OS overall survival
  2. aComprising the GSE52634 and GSE53622 datasets
  3. bLog-rank test was used